MyFinsight
Home
Blog
About
Back
Income Statement
ADIAL PHARMACEUTICALS, INC. (ADIL)
ADIAL PHARMACEUTICALS, INC. (ADIL)
source: myfinsight.com
Change in fair value of
milestone warrant rights...
-$8,280,000
Interest income
$58,000
(144.24%↑ Y/Y)
Net loss
-$51,989,000
(-2554.46%↓ Y/Y)
Total other income
(expense)
$36,000
(147.47%↑ Y/Y)
Loss on
extinguishment
-$6,054,000
Financing expense related
to milestone...
$2,067,000
Loss on equity method
investment
-$181,000
(-83.33%↓ Y/Y)
Loss from operations
-$52,025,000
(-2663.30%↓ Y/Y)
Total operating
expenses
$52,025,000
(2663.30%↑ Y/Y)
Acquired in process
research and development
-$46,185,000
General and
administrative expenses
$5,400,000
(369.40%↑ Y/Y)
Research and development
expenses
$440,000
(-39.92%↓ Y/Y)
Back